VolitionRx Limited ( VNRX) - Key Metrics
VNRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.01 | -$0.05 | -$0.03 | -$0.03 |
| 2025Q2 | $0 | -$0.06 | -$0.06 | -$0.06 |
| 2025Q1 | $0 | -$0.06 | -$0.04 | -$0.04 |
VNRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -3.41 |
| 2025Q2 | ? | -3.10 |
| 2025Q1 | ? | -2.54 |
VNRX
Price: $2.08
52 week price:
Earnings Per Share: -4.40 USD
Exchange: ASE
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 202636
Market Capitalization: 19.0 million